Last updated on June 2020

Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients


Brief description of study

To demonstrate the efficacy and safety of acarbose and metformin loose-dose combination as compared to metformin monotherapy in the treatment of subjects with T2DM that is inadequately controlled by metformin alone

Clinical Study Identifier: NCT03349684

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.